XML 68 R58.htm IDEA: XBRL DOCUMENT v3.23.2
Segment Data (Schedule of Net Sales from External Customers by Products) (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 6 Months Ended
Jul. 01, 2022
Jun. 30, 2023
Jun. 16, 2022
Jun. 30, 2023
Jun. 16, 2022
Segment Reporting Information          
Net sales $ 85.0 $ 475.0 $ 383.7 $ 899.6 $ 874.6
Specialty Brands | Operating Segments          
Segment Reporting Information          
Net sales 58.2 280.1 247.7 532.1 587.1
Specialty Generics          
Segment Reporting Information          
Net sales 26.8 194.9 136.0 367.5 287.5
Specialty Generics | Operating Segments          
Segment Reporting Information          
Net sales 26.8 194.9 136.0 367.5 287.5
Acthar | Specialty Brands          
Segment Reporting Information          
Net sales 27.5 116.8 94.2 198.8 221.9
Inomax | Specialty Brands          
Segment Reporting Information          
Net sales 13.5 76.9 66.8 159.6 165.8
Therakos immunotherapy | Specialty Brands          
Segment Reporting Information          
Net sales 10.2 62.9 49.7 121.6 109.6
Amitiza [Member] | Specialty Brands          
Segment Reporting Information          
Net sales [1] 5.8 18.6 33.8 43.1 81.5
Other | Specialty Brands          
Segment Reporting Information          
Net sales 1.2 1.5 3.2 3.4 8.3
Opioids | Specialty Generics          
Segment Reporting Information          
Net sales 8.7 72.1 38.8 134.3 88.8
ADHD | Specialty Generics          
Segment Reporting Information          
Net sales 1.8 19.0 6.8 41.4 17.5
Addiction Treatment | Specialty Generics          
Segment Reporting Information          
Net sales 2.5 16.1 14.1 31.7 30.0
Other Generics | Specialty Generics          
Segment Reporting Information          
Net sales 0.1 2.4 2.0 4.2 4.9
Generics | Specialty Generics          
Segment Reporting Information          
Net sales 13.1 109.6 61.7 211.6 141.2
Controlled substances | Specialty Generics          
Segment Reporting Information          
Net sales 1.7 20.9 17.2 39.4 37.6
APAP | Specialty Generics          
Segment Reporting Information          
Net sales 11.3 59.8 50.2 106.2 96.5
Other API | Specialty Generics          
Segment Reporting Information          
Net sales 0.7 4.6 6.9 10.3 12.2
API | Specialty Generics          
Segment Reporting Information          
Net sales 13.7 85.3 74.3 155.9 146.3
Terlivaz | Specialty Brands          
Segment Reporting Information          
Net sales $ 0.0 $ 3.4 $ 0.0 $ 5.6 $ 0.0
[1] Amitiza consists of both product net sales and royalties. Refer to Note 2 for further details on Amitiza's revenues.